« Return to News | Awards & Advancement

SAFE-BioPharma named Computerworld Laureate

Monday, March 26, 2012 03:49 PM

SAFE-BioPharma, the global digital identity and digital signature standard for the life sciences and healthcare sectors, has been named a 2012 Computerworld Laureate.

IDG’s Computerworld Honors Program, which recognizes visionary applications of information technology promoting positive social, economic and educational change, has recognized the SAFE-BioPharma standard for its role in facilitating cloud-based collaboration between National Cancer Institute researchers and their private sector counterparts to accelerate initiation of a cancer clinical trial while lowering its costs and reducing paper-reliance. 

The public and private cancer researchers were provisioned with interoperable digital identities, a form of software installed on a computer, cell phone or other device, which establishes a close link with the user's proven identity and allows for the application of digital signatures to electronic documents. Unlike simple electronic signatures, digital signatures cryptographically guarantee the integrity of documents to which they are affixed. In the pilot study, the electronic documents were placed in the cloud, where the researchers were able to access, sign, and exchange them immediately. Prior to the study, the signature process was delayed by travel and the use of courier, fax, etc.

The 2012 Computerworld Laureates will be recognized publicly at the laureate medal ceremony and gala evening on June 4 in Washington, D.C.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.